In this study, administration of a GA targeting antibody in a mouse model of C9orf72‐ALS/FTD, successfully attenuated neurodegeneration, improved behavioral outcomes, and increased survival (Nguyen et al, 2020). The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.